Boston/ Real Estate & Development

Genzyme Pays $58 Million for Northborough Biotech Site It Already Called Home

AI Assisted Icon
Published on November 20, 2026
Genzyme Pays $58 Million for Northborough Biotech Site It Already Called Home11 Forbes Rd. — Genzyme Facility And Purchase Site
Google Street View

Genzyme Corp. has bought the Northborough facility it has called home for more than a decade, paying $58 million for the 11 Forbes Road property on Nov. 16. The pharmaceutical testing, packaging and distribution center sits on roughly 19 acres near Northborough's border with Marlborough, and Genzyme had been leasing the site before closing the deal to own it outright.

The sale was first reported by Community Advocate, which detailed the transaction between Genzyme and the previous owner, WCV–11 Forbes LLC, an entity managed by Boston-based Camber Development. Genzyme Corp. is part of French pharmaceutical giant Sanofi, according to the same report, and the company has occupied the facility since 2010.

From Water Bottling to Biotech

The building at 11 Forbes Road has had a varied life before becoming a pharmaceutical hub. The property once served as a Poland Spring water distribution facility, and it underwent extensive renovations before Genzyme's operations began there. Today the seed facts describe a complex that includes offices, a laboratory, and warehouse space used for shipping and receiving, quality control, refrigerated storage, and packaging operations.

Accounts differ slightly on the building's exact footprint. The seed facts put it at 211,000 square feet, while the Telegram & Gazette previously described it as a 212,000-square-foot life sciences building. That earlier Telegram & Gazette report also noted that Sanofi Genzyme held a long-term lease on the two buildings at the site, using them as a packaging, testing and distribution facility.

A Sharp Jump From the 2021 Sale Price

Genzyme's $58 million purchase price marks a steep climb from the property's last sale. According to the seed facts, the 2026 price exceeded the 2021 purchase price by $25 million. That earlier deal saw Camber Development and Wheelock Street Capital pay $33 million for the property in 2021, acquiring it from Capri EGM while Genzyme remained the site's tenant. Connect CRE reported the same figure at the time, noting the sales price was $33 million. The Telegram & Gazette described that 2021 transaction as a sale to a joint venture between Connecticut-based Wheelock Street Capital and Boston real estate investor Camber Development.

The property's ownership history before that is murkier. The seed facts describe a 2016 transaction worth nearly $21 million, but sources disagree on who was involved. The Telegram & Gazette reported the property was bought by CEGM Northborough LLC in 2016 for $21 million from Cornerstone Real Estate Advisers, while the Worcester Business Journal reported that Capri EGM purchased the property from GN11 Forbes Road LLC, a Connecticut real estate company.

Part of a Busier Northborough Industrial Market

Genzyme's purchase lands amid other notable commercial property activity in the same Northborough submarket. The Worcester Business Journal also reported that a FedEx freight facility at 300 Bartlett St. sold for $36 million on Nov. 3, with LaSalle Investment Management purchasing the 54,504-square-foot truck terminal from NorthBridge Partners of Wakefield. That property, situated on about 25 acres near Interstate 495, had previously traded hands when NorthBridge Partners bought it for $19 million in 2018, per the same outlet's reporting.

Together, the two deals point to continued investor interest in Northborough's industrial and life-sciences real estate, even as building specifications and ownership records from years past remain difficult to fully reconcile across different accounts.

Boston-Real Estate & Development